Clinical Trial Update: A Study of Revumenib and Mezigdomide in People With Leukemia [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update describing a Phase 1/2 study of Revumenib and Mezigdomide for various forms of leukemia, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Acute Myeloid Leukemia
• Leukemia
• Mixed Phenotype Acute Leukemia
• Relapse Leukemia

Drugs mentioned

• Mezigdomide (mezigdomide)
• Revumenib (revumenib)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Leukemia, Acute Leukemia | Phase 1, Phase 2 | Status: RECRUITING